Immugo Tablet contains Azathioprine 50mg, an immunosuppressive agent primarily used to prevent organ transplant rejection and to treat autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. Azathioprine works by inhibiting purine synthesis, thereby suppressing the proliferation of immune cells, particularly lymphocytes, which play a key role in the immune response. This mechanism helps reduce the activity of the immune system, preventing it from attacking the body’s own tissues or transplanted organs. Immugo Tablet is prescribed under strict medical supervision due to its potent immunosuppressive effects and potential side effects, which may include bone marrow suppression, increased risk of infections, liver toxicity, and gastrointestinal disturbances. Regular monitoring of blood counts and liver function tests is essential during therapy to detect adverse effects early. Dosage and duration of treatment with Immugo Tablet vary depending on the condition being treated and patient response. It is contraindicated in patients with hypersensitivity to azathioprine or those with active infections. Patients should inform their healthcare provider about any other medications they are taking to avoid drug interactions. Immugo Tablet should be used cautiously in pregnancy and lactation, with benefits and risks carefully weighed by the prescribing physician.